FDA Approves First Cream for Treating Chronic Hand Eczema

Adobe Stock
Adobe Stock
Published on

Key Takeaways

  • The U.S. Food and Drug Administration has given its nod to a new treatment for chronic hand eczema

  • Anzupgo is now the only topical therapy specifically approved for chronic hand eczema

  • This form of eczema affects about 10% of the U.S. population

Related Stories

No stories found.
Clinical Briefing Report
clinicalbriefingreport.com